| Deterring Inefficient Pharmaceutical Litigation: An Economic Rationale for the FDA Regulatory Compliance Defense WK Viscusi, SR Rowland, HL Dorfman, CJ Walsh Seton Hall L. Rev. 24, 1437, 1993 | 100 | 1993 |
| The Learned Intermediary Doctrine: The Correct Prescription for Drug Labeling CJ Walsh, SR Rowland, HL Dorfman Rutgers L. Rev. 48, 821, 1995 | 51 | 1995 |
| Presumption of Innocence: FDA's Authority to Regulate the Specifics of Prescription Drug Labeling and the Preemption Debate HL Dorfman, VM Quinn, EA Brophy Food & Drug LJ 61, 585, 2006 | 32 | 2006 |
| Surfing the net in shallow waters: product liability concerns and advertising on the Internet MA Moberg, JW Wood, HL Dorfman Food and Drug Law Journal 53 (2), 213-224, 1998 | 20 | 1998 |
| " Dot. Com Medicine"—Labeling in an Internet Age JM Wood, HL Dorfman Food and Drug Law Journal 56 (2), 143-178, 2001 | 15 | 2001 |
| 2009 Revision to the PhRMA code on interactions with healthcare professionals: challenges and opportunities for the pharmaceutical industry in the age of compliance HL Dorfman Campbell L. Rev. 31, 361, 2008 | 11 | 2008 |
| Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry HL Dorfman, LP Reig Food and Drug Law Journal 59 (4), 595-615, 2004 | 10 | 2004 |
| The Effect of Products Liability Litigation on Innovation: Deterring Inefficient Pharmaceutical Litigation: An Economic Rationale for the FDA Regulatory Compliance Defense WK Viscusi, SR Rowland, HL Dorfman, CJ Walsh Seton Hall L. Rev. 24, 1437, 1994 | 9 | 1994 |
| Pharmaceutical Compliance and Enforcement Answer Book HL Dorfman Practising Law Institute, 2023 | | 2023 |
| Bioethics/PhRMA Adopts Revised Marketing Code HL Dorfman, A Bennett, AE Lewis, JJ Liu JOURNAL OF BIOLAW AND BUSINESS 12 (1), 64-65, 2009 | | 2009 |
| AdvaMed Updates Code of Ethics on Interactions with Health Care Professionals HL Dorfman, GH Levine, EV Brunts, AF Cacozza, AE Lewis JOURNAL OF BIOLAW AND BUSINESS 12 (2), 58-60, 2009 | | 2009 |
| Amendments to the PHRMA Code on Interactions with Healthcare Professionals H Dorfman | | 2009 |
| Panel Discussion: Important Legal Developments in Health Law M Stewart, W William, D McCord, H Dorfman, RH Wyman Jr | | 2009 |
| REPORTS TO THE READER HL Dorfman, VM Quinn, EA Brophy | | |
